O.da SilvaC
AOD-9604 is well soluble, any turbidity indicates degradation or contamination
W., Casas-Ganem, J., Wyatt, C., Kubo, T., et al
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Furthermore, certain medications, like proton pump inhibitors for acid reflux, metformin for diabetes, and some medications for peptic ulcers or heartburn, can impair your bodys ability to process Vitamin B12
PCR, polymerase chain reaction